Insuffisance Cardiaque Sous Carfilzomib: étude Prospective
Insuffisance Cardiaque Sous Carfilzomib: étude Prospective
Cardiovascular toxicity of carfilzomib, a last generation proteasome inhibitor, is highly incident according to retrospective data. Prospective cohort study of patients initiated on carfilzomib.
Inclusion Criteria:
Exclusion Criteria:
mariana.mirabel@aphp.fr+33156095636